These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9417289)

  • 1. [The pathogenesis of viral hepatitis C].
    Tecu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):167-72. PubMed ID: 9417289
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.
    Ichiki Y; He XS; Shimoda S; Ishibashi H; Keeffe EB; Rossaro L; Gershwin ME
    Autoimmun Rev; 2005 Feb; 4(2):82-95. PubMed ID: 15722254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
    Rosen HR
    Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune responses against hepatitis C virus.
    Koziel MJ
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S25-31. PubMed ID: 16265610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for immune responses in the pathogenesis of hepatitis C?
    Mondelli MU
    J Hepatol; 1996 Aug; 25(2):232-8. PubMed ID: 8878788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune cellular response in hepatitis C].
    López Labrador FJ
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():29-34. PubMed ID: 11279892
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of chronic hepatitis C virus infection.
    Nelson DR; Lau JY
    Antivir Ther; 1998; 3(Suppl 3):25-35. PubMed ID: 10726053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
    Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
    Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV persistence and immune evasion in the absence of memory T cell help.
    Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM
    Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
    Grüner NH; Gerlach TJ; Jung MC; Diepolder HM; Schirren CA; Schraut WW; Hoffmann R; Zachoval R; Santantonio T; Cucchiarini M; Cerny A; Pape GR
    J Infect Dis; 2000 May; 181(5):1528-36. PubMed ID: 10823750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic T cells and liver tolerance.
    Crispe IN
    Nat Rev Immunol; 2003 Jan; 3(1):51-62. PubMed ID: 12511875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.